Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.
about
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.Are Systematic Screening for Vitamin D Deficiency and Vitamin D Supplementation Currently Feasible for Ankylosing Spondylitis Patients?Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.Posttraumatic stress disorder and correlates of disease activity among veterans with ankylosing spondylitis.Secukinumab: a promising therapeutic option in spondyloarthritis.Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.Down-Regulation of lncRNA-AK001085 and its Influences on the Diagnosis of Ankylosing Spondylitis.Dissecting the Underlying Pharmaceutical Mechanism of Chinese Traditional Medicine Yun-Pi-Yi-Shen-Tong-Du-Tang Acting on Ankylosing Spondylitis through Systems Biology Approaches.I-BET151 inhibits expression of RANKL, OPG, MMP3 and MMP9 in ankylosing spondylitis in vivo and in vitro.Identification of potential pathogenic genes associated with osteoporosis.Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up.Unmet Needs in Axial Spondyloarthritis.Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus
P2860
Q33624763-01D42B0C-1314-4F54-BD18-E8C7F95FAAC8Q37364345-FD7695A6-ABD9-490E-B001-BCA694E7D48EQ37587350-A4023D88-465C-44A0-AF20-DAF992BEE6B2Q37649641-5CB5EC76-F4D6-4B29-9782-DABAEEB9E7E4Q38608792-4E27B42A-3A43-4279-B7ED-75F48284BCEEQ38903129-89344DF0-9DA5-4308-9B47-1EBB67D5B836Q40042219-EB48F611-A560-4633-B33F-77767D23303BQ41249188-99AF51B0-6FB7-492A-800A-8B8FD09CD0A6Q42658861-7576CB10-66ED-4231-8C1C-63CD549EC50DQ42676009-9CDEBBB8-A5B0-4E39-BCCE-E802387A7956Q47370889-FBEEDA47-E549-49FD-A7A4-5135A9432782Q47400940-E9E37A23-F05A-4D79-982F-D334BA076FB0Q48287506-4C2E9117-DC86-479A-8182-8D57CB539480Q52727983-B26144F1-205B-4A39-882F-E19F5E616CD4Q58694777-5D283F43-9BD7-4546-A510-B8ED47DE9E9E
P2860
Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biomarkers for diagnosis, moni ...... s and axial spondyloarthritis.
@ast
Biomarkers for diagnosis, moni ...... s and axial spondyloarthritis.
@en
type
label
Biomarkers for diagnosis, moni ...... s and axial spondyloarthritis.
@ast
Biomarkers for diagnosis, moni ...... s and axial spondyloarthritis.
@en
prefLabel
Biomarkers for diagnosis, moni ...... s and axial spondyloarthritis.
@ast
Biomarkers for diagnosis, moni ...... s and axial spondyloarthritis.
@en
P2860
P1476
Biomarkers for diagnosis, moni ...... s and axial spondyloarthritis.
@en
P2093
John D Reveille
P2860
P304
P356
10.1007/S10067-015-2949-3
P577
2015-05-05T00:00:00Z